A breast cancer patient was taking the prescription Femara for her ongoing therapy. But when her husband’s company stopped offering employees insurance coverage she did not know how she could afford the expensive drug for the next two years needed to complete her therapy. The brand-name medication would cost the patient $500 per month. She had been receiving prescription assistance, …